• Sign Up

Use coupon code EXTENDEDHOLIDAY2020 at checkout for 20% off

Cystic Fibrosis Related Diabetes


[1] Moheet A,Moran A, CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis. Pediatric pulmonology. 2017 Nov;     [PubMed PMID: 28714601]
[2] Moran A,Pillay K,Becker D,Granados A,Hameed S,Acerini CL, ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents. Pediatric diabetes. 2018 Oct;     [PubMed PMID: 30094886]
[3] Yoon JC, Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis-Related Diabetes. Journal of the Endocrine Society. 2017 Nov 1;     [PubMed PMID: 29264462]
[4] Olivier AK,Yi Y,Sun X,Sui H,Liang B,Hu S,Xie W,Fisher JT,Keiser NW,Lei D,Zhou W,Yan Z,Li G,Evans TI,Meyerholz DK,Wang K,Stewart ZA,Norris AW,Engelhardt JF, Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. The Journal of clinical investigation. 2012 Oct;     [PubMed PMID: 22996690]
[5] Löhr M,Goertchen P,Nizze H,Gould NS,Gould VE,Oberholzer M,Heitz PU,Klöppel G, Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Archiv. A, Pathological anatomy and histopathology. 1989;     [PubMed PMID: 2492695]
[6] Terliesner N,Vogel M,Steighardt A,Gausche R,Henn C,Hentschel J,Kapellen T,Klamt S,Gebhardt J,Kiess W,Prenzel F, Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function. Journal of pediatric endocrinology     [PubMed PMID: 28245190]
[7] Moran A,Brunzell C,Cohen RC,Katz M,Marshall BC,Onady G,Robinson KA,Sabadosa KA,Stecenko A,Slovis B, Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes care. 2010 Dec;     [PubMed PMID: 21115772]
[8] Clemente León M,Bilbao Gassó L,Moreno-Galdó A,Campos Martorrell A,Gartner Tizzano S,Yeste Fernández D,Carrascosa Lezcano A, Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients. Endocrinologia, diabetes y nutricion. 2018 Jan;     [PubMed PMID: 29137964]
[9] Moran A,Dunitz J,Nathan B,Saeed A,Holme B,Thomas W, Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes care. 2009 Sep;     [PubMed PMID: 19542209]
[10] Ntimbane T,Krishnamoorthy P,Huot C,Legault L,Jacob SV,Brunet S,Levy E,Guéraud F,Lands LC,Comte B, Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2008 Sep;     [PubMed PMID: 18420468]
[11] Hunt WR,Zughaier SM,Guentert DE,Shenep MA,Koval M,McCarty NA,Hansen JM, Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes. American journal of physiology. Lung cellular and molecular physiology. 2014 Jan 1;     [PubMed PMID: 24097557]
[12] Lavie M,Fisher D,Vilozni D,Forschmidt R,Sarouk I,Kanety H,Hemi R,Efrati O,Modan-Moses D, Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status. Diabetes research and clinical practice. 2015 Dec;     [PubMed PMID: 26508676]
[13] Schwarzenberg SJ,Thomas W,Olsen TW,Grover T,Walk D,Milla C,Moran A, Microvascular complications in cystic fibrosis-related diabetes. Diabetes care. 2007 May;     [PubMed PMID: 17322485]